Prostate cancer is the fourth most common cancer worldwide and is the second most lethal cancer (
1,
2). The incidences of prostate cancer have been rising recently; for example, in the United States, there are expected to be about 221,000 new prostate cancer diagnoses and about 27,500 prostate cancer deaths in 2015 (
3,
4). It has been evident that prostate cancer cases are growing in Iranian men (
5). In 2010 there were estimated to be 3856 new cases of prostate cancer, making it the third most commonly diagnosed cancer in Iranian men (
6). In this regard, according to the Iranian annual national registration center report, the incidence of prostate cancer in Hamadan province has been reported 6.87 cases per hundred thousand population over 50 years in 2010 (
6).
Despite major differences in the incidence of prostate cancer, it can primarily be considered associated with men older than 65 years, since 75% of new cases are diagnosed in men over 65 years (
6,
7). It is due to the asymptomatic nature of the disease in the early stages. The symptoms are often implying locally advanced or metastatic disease (
6). However, racial differences (
3), genetic and environmental factors, family history (
1), hormonal changes related to aging (
8,
9) infection, poor nutrition (especially unsaturated fats) (
10), smoking and alcohol consumption (
11), etc. can be mentioned as the other reasons. The four fold increase in the number of men older than 65 years by 2050 (
12) and the huge cost imposed on the health care systems due to prostate cancer (
2) imply the importance of prostate cancer more (
12). Meanwhile, owing to asymptomatic nature of prostate cancer, to reduce mortality, screening can be used in asymptomatic patients to diagnose the prostate cancer (
8). Therefore, American cancer society suggested prostate cancer screening for all men over 50 years (
13). There are different screening and diagnostic procedures including urodynamic studies, sonography, laboratory tests, symptoms and physical examinations (
14). Serologic test for assessing prostate-specific antigen (PSA) level is the most important method, which is also the most practical one, easiest and most sensitive detection test (97% specificity and 67% sensitivity). It is recommended as the first diagnostic test and its digital rectal exam (DRE) for diagnosis and follow-up for prostate cancer for individuals over 50 years is advised (
9,
13). Timely treatment and eradication of prostate cancer before metastasis can be achieved by early diagnosis with the PSA test (
13).
The results of various studies are emphasized on the effectiveness of PSA screening test in the diagnosis of cancer. They also introduce factors such as aging, higher income and better general health, as predictors of screening tests. These studies have emphasized risk-awareness strategies and intervention based on the increased information in prostate cancer prevention programs for health educators (
12,
15-
17).